Prostatype Genomics AB (publ)
Research Prostatype Genomics AB (publ) (PGO0) on Bullrun: market cap EUR 1.88M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPGO0
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 1.88M
- Financial periodFY2025
- RevenueEUR 594.00K
- Revenue growth198.5%
- Net income-EUR 44.50M
- Free cash flow-EUR 37.24M
- Gross margin100.0%
Valuation Snapshot
latest market cap is EUR 1.88M.
About Prostatype Genomics AB (publ)
Prostatype Genomics AB (publ) manufactures, markets, and sells prognostic gene tests. The company offers a Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, gleason score, RTqPCR kit, patient database and algorithms, Prostatype Web System (PWS), and tumor stage, as well as calculates the P-score. Its test is based on a database containing prostate cancer patients; and provides decision support for patients and doctors when making a treatment decision.
Frequently asked questions
What is Prostatype Genomics AB (publ)'s market cap?
Prostatype Genomics AB (publ)'s market capitalization is EUR 1.88M.
What does Prostatype Genomics AB (publ) do?
Prostatype Genomics AB (publ) manufactures, markets, and sells prognostic gene tests. The company offers a Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, gleason score, RTqPCR kit, patient database and algorithms, Prostatype Web System...